Placental polyps and acquired uterine arteriovenous malformations: management dilemma

Conclusions Dilatation and curettage is therapeutic for evacuation of RPOC and non-invasive hydatiform mole, but can induce massive, life-threatening bleeding in AVM, thus contraindicated in cases of high velocity flow more than 20cm /sec. Treatment of uterine AVM varies from medical management (hormonal therapy), minimally invasive uterine artery embolization to more definitive surgical hysterectomy, depending upon age of the patient, size and site of the lesion, and the desire to retain future fertility [5].
Source: Reviews in Vascular Medicine - Category: Cardiology Source Type: research